CNS/Neurology Market Research Reports & Industry Analysis
A neurologist is a medical doctor that specializes in the diagnosis, treatment and management of illnesses affecting the brain, spinal cord, and nervous system. Neurologists must complete at least three years of specialized training in neurology, after completing medical school. A neurosurgeon must go through much more extensive and rigorous schooling and training. On top of diagnosing and treating neurological disorders, neurosurgeons can also perform surgery on the brain, spinal cord, and nerves.
Pharmaceuticals in CNS/Neurology are one of leading fields in medicine in terms of funding and research. On top of growing patient numbers, there remains a comparatively high unmet need in treatment of many neurological diseases. With the potential of being one of the most lucrative therapy areas in the future pharmaceutical Industry, Alzheimer's disease offers the greatest commercial opportunity for pharmaceutical companies in neurology. Many of the therapeutic drugs used to treat CNS/Neurological disorders have lost their patent protection or market exclusivity, leading to greater research and market opportunities for competing pharmaceutical and medical device companies. Despite the widespread use of CNS drugs, knowledge of these agents is limited due to the anatomic and neurochemical complexity of the brain and spinal cord.
CNS/Neurology Industry Research & Market Reports
-
Cannabidiol Market Assessment, By Species [Indica, Sativa, Hybrid], By Route of Administration [Oral, Topical, Others], By Form [Oils, Capsules, Tinctures], By Therapeutic Application [Cancer, Migraine, Epilepsy, Anxiety and Depression, Others], By End-user [Pharmaceutical Companies, Hospital Pharmacies, Online Pharmacies, Retail Stores, Research and Development Centers, Others], By Region, Opportunities and Forecast, 2017-2031F
... Pharmacies, Online Pharmacies, Retail Stores, Research and Development Centers, Others], By Region, Opportunities and Forecast, 2017-2031F Global cannabidiol market is projected to witness a CAGR of 18% during the forecast period 2024-2031, growing from USD ... Read More
-
Brain Cancer Market Assessment, By Drug [Carmustine, Cisplatin, Bevacizumab, Temozolomide, Belzutifan, Others], By Therapy [Chemotherapy, Targeted Therapy, Immunotherapy, Others], By Indication [Pituitary, Glioma, Meningioma, Others], By End-user [Hospitals, Cancer Centers, Diagnostic Laboratories], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F
... [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F Global brain cancer market is projected to witness a CAGR of 10.03% during the forecast period 2024-2031, growing from USD 2.51 billion in ... Read More
-
Drug Delivery Systems Market Assessment, By Product [Prefilled Syringes, Autoinjectors, Infusion Pumps, Metered Dose Inhalers, Nebulizers, Nasal Sprays, Eyedroppers, Intrauterine Devices], By Route of Administration [Pulmonary Drug Delivery, Transmucosal Drug Delivery, Nasal Drug Delivery, Oral Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, Injectable Drug Delivery, Ocular Drug Delivery], By Application [Autoimmune Diseases, Cardiovascular Diseases, Cancer, Infectious Diseases, Respiratory Diseases, Central Nervous System Diseases, Diabetes, Others], By End-user [Hospitals, Ambulatory Surgical Centers, Home Care Settings, Diagnostic Centers, Others], By Region, Opportunities and Forecast, 2017-2031F
... Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, Injectable Drug Delivery, Ocular Drug Delivery], By Application [Autoimmune Diseases, Cardiovascular Diseases, Cancer, Infectious Diseases, Respiratory Diseases, Central Nervous System Diseases, Diabetes, Others], By End-user [Hospitals, Ambulatory ... Read More
-
Brain Health Functional Food And Beverage Market - 2024-2031
... a CAGR of 5.32% during the forecast period 2024-2031. The global brain health functional food and beverage market has witnessed significant growth and developments. Consumers are highly adopting functional foods and beverages compared to conventional ... Read More
-
Technology Landscape, Trends and Opportunities in the Global Neuroprosthetic Market
... of new technologies such as vagus nerve stimulation and spinal cord stimulation technology are creating significant potential for advanced neuroprosthetic devices in various medical platforms due to its benefits of reduction in the frequency of ... Read More
-
Bioanalytical Testing Services Market – By Molecule Type (Small, Large), Test Type (DMPK, Biomarker, Virology, Serology, Immunogenicity Testing), Application (Oncology, Neurology, Cardiology), By End-use & Forecast, 2024 – 2032
... at over 8.6% CAGR between 2024 and 2032, driven by the increasing prevalence of chronic diseases and the growing demand for personalized medicine. As per WHO, every year, 41 million individuals succumb to chronic diseases, ... Read More
-
Mental Health Screening Market by Indication (Depression, Bipolar, Schizophrenia, ADHD, Alzheimer, Dementia), Screening (Self, Interview, Observation, Biomarker), Technology (mHealth, Remote Platform, Telehealth), Age, Setting - Global Forecast to 2029
... projected to reach USD 1.8 billion by 2029 from USD 0.9 billion in 2023, at a CAGR 12.2% during the forecast period. The rising awareness of mental health issues due to the growing geriatric population ... Read More
-
Global Schizophrenia Treatments Market Growth (Status and Outlook) 2024-2030
... downstream market, the Schizophrenia Treatments is forecast to a readjusted size of US$ 10890 million by 2030 with a CAGR of 1.8% during review period. The research report highlights the growth potential of the global ... Read More
-
Neurology Clinical Trials Market Size, Trends, Analysis, and Outlook By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Amyotrophic Lateral Sclerosis (ALS), Muscle regeneration, Others), by Region, Country, Segment, and Companies, 2024-2030
... Traumatic Brain Injury (TBI), Amyotrophic Lateral Sclerosis (ALS), Muscle regeneration, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Neurology Clinical Trials market size is poised to register 5.35% growth from 2024 to 2030, ... Read More
-
Neurology Devices Market Size, Trends, Analysis, and Outlook By Product (Neurostimulation, Interventional Neurology, CSF Management Devices, Neurosurgery Devices), By Neurostimulation (Spinal Cord Stimulation, Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electric Stimulation), By Interventional Neurology (Aneurysm Coiling and Embolization, Neurovascular Catheters, Cerebral Balloon Angioplasty &Stents, Neurothromobectomy), By CSF Management Devices (Cerebral Shunts, Cerebral External Drainage), By Neurosurgery Devices (Ultrasonic Aspirators, Stereotactic Systems, Neuroendoscopes, Aneurysm Clips), by Region, Country, Segment, and Companies, 2024-2030
... Gastric Electric Stimulation), By Interventional Neurology (Aneurysm Coiling and Embolization, Neurovascular Catheters, Cerebral Balloon Angioplasty &Stents, Neurothromobectomy), By CSF Management Devices (Cerebral Shunts, Cerebral External Drainage), By Neurosurgery Devices (Ultrasonic Aspirators, Stereotactic Systems, Neuroendoscopes, Aneurysm ... Read More
-
Morphine Drugs Market Size, Trends, Analysis, and Outlook By Product (Immediate Release/ Short Acting Opioids (Codeine, Oxycodone, Hydrocodone, Fentanyl, Morphine, Hydroxymorphone, Oxymorphone, Propoxyphene, Others), Extended Release/Long Acting Opioids (Oxycodone, Hydrocodone, Methadone, Fentanyl, Morphine, Oxymorphone, Tapentadol, Buprenorphine, Hydromorphone, Others)), By Application (Pain Relief (Cancer Pain, Post-Operative Care, Lower Back Pain, Orthopedic, Neuropathic, Fibromyalgia), Anesthesia, Cough Suppression, Diarrhoea Suppression, De-addiction), by Region, Country, Segment, and Companies, 2024-2030
... Buprenorphine, Hydromorphone, Others)), By Application (Pain Relief (Cancer Pain, Post-Operative Care, Lower Back Pain, Orthopedic, Neuropathic, Fibromyalgia), Anesthesia, Cough Suppression, Diarrhoea Suppression, De-addiction), by Region, Country, Segment, and Companies, 2024-2030 The global Morphine Drugs market ... Read More
-
Biopharmaceuticals Contract Manufacturing Market Size, Trends, Analysis, and Outlook By Source (Mammalian, Non-mammalian), By Service (Process Development, Fill & Finish Operations, Analytical & QC studies, Packaging), By Product (Biologics, BiosimilarsOthers), By Therapeutic Area (Oncology, Autoimmune Diseases, Metabolic Diseases, Cardiovascular Diseases, Neurology, Infectious Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030
... Diseases, Metabolic Diseases, Cardiovascular Diseases, Neurology, Infectious Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Biopharmaceuticals Contract Manufacturing market size is poised to register 5.82% growth from 2024 to 2030, presenting significant ... Read More
-
Erythropoietin Drugs Market Size, Trends, Analysis, and Outlook By Type (Biologics, Biosimilars), By Product (Erythropoietin, Darbepoetin-alfa), By Application (Cancer, Renal Diseases, Neurology, Others), by Region, Country, Segment, and Companies, 2024-2030
... size is poised to register 4.85% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Erythropoietin Drugs market across By Type (Biologics, Biosimilars), ... Read More
-
Video Telemedicine Market Size, Trends, Analysis, and Outlook By Communication Technology (3G, 4G, Satellite Communication, ADSL and Broadband ISDN), By Application (Cardiology, Dermatology, Neurology and Psychiatry, Orthopaedics, Oncology, Radiology, Pathology, Gynaecology and Dentistry), By Deployment (Cloud- Based Video Conferencing, On- Premise Video Conferencing), By Component (Hardware, Software), By End-user (Hospitals, Clinics, Home Care Services, Others), by Region, Country, Segment, and Companies, 2024-2030
... (Cloud- Based Video Conferencing, On- Premise Video Conferencing), By Component (Hardware, Software), By End-user (Hospitals, Clinics, Home Care Services, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Video Telemedicine market size is poised ... Read More
-
Medical Marijuana Market Size, Trends, Analysis, and Outlook By Product (Flower, Oil & Tinctures ), By Application (Cancer, Chronic Pain, Depression and Anxiety, Arthritis, Diabetes, Glaucoma, Migraines, Epilepsy, Multiple Sclerosis, AIDS, Amyotrophic Lateral Sclerosis, Alzheimer’s Disease, Post-Traumatic Stress Disorder (PTSD), Parkinson's Disease, Tourettes, Others), by Region, Country, Segment, and Companies, 2024-2030
... Disease, Post-Traumatic Stress Disorder (PTSD), Parkinson's Disease, Tourettes, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Medical Marijuana market size is poised to register 21.66% growth from 2024 to 2030, presenting significant growth ... Read More
-
Deep Brain Stimulation in Parkinson's Disease Market Size, Trends, Analysis, and Outlook By Product (Single Channel, Dual Channel), By End-User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers), by Region, Country, Segment, and Companies, 2024-2030
... The global Deep Brain Stimulation in Parkinson's Disease market size is poised to register 10.92% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the ... Read More
-
Magnetoencephalography Market Size, Trends, Analysis, and Outlook By Application (Clinical (Dementia, Autism, Schizophrenia,-Multiple Sclerosis, Stroke, Epilepsy), Research), By End-user (Hospitals, Imaging centers, Academic and research institutes), by Region, Country, Segment, and Companies, 2024-2030
... Magnetoencephalography market size is poised to register 4.94% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Magnetoencephalography market across By Application (Clinical ... Read More
-
Psychedelic Drugs Market Size, Trends, Analysis, and Outlook By Drug Type (Gamma Hydroxybutyric Acid (GHB), Ketamine, Psilocybin, Lysergic Acid Diethylamide (LSD), 3,4-MethylEnedioxyMethamphetamine, Others), By Application (Treatment Resistant Depression, Opiate Addiction, Post-traumatic Stress Disorder, Narcolepsy, Panic Disorders, Others), By Distribution Channel, Hospital pharmacy, Retail pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030
... Disorders, Others), By Distribution Channel, Hospital pharmacy, Retail pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Psychedelic Drugs market size is poised to register 13.57% growth from 2024 to 2030, presenting significant ... Read More
-
Brain Implants Market Size, Trends, Analysis, and Outlook By Product (Deep Brain Stimulator, Spinal Cord Stimulator, Vagus Nerve Stimulator), By Application (Chronic pain, Epilepsy, Parkinson's, Depression, Essential Tremor, Alzheimer's), by Region, Country, Segment, and Companies, 2024-2030
... 2024-2030 The global Brain Implants market size is poised to register 10.1% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Brain Implants ... Read More
-
Brain Cancer Diagnostics Market Size, Trends, Analysis, and Outlook By Diagnostic Type (Imaging Test, Lumbar Puncture, Biopsy, Molecular Testing, Platform and Services, Cerebral Arteriogram, Neurological & Hearing Tests/Neurocognitive Assessments, Electroencephalography, EEG, Others), By Cancer (Acoustic Neuroma, Astrocytomas, Craniopharyngiomas, Ganglioneuromas, Glioblastoma Multiforme, Meningiomas, Ependymomas, Oligodendroglioma, Low-Grade Tumors, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Diagnostic Centers & Research Institutes, Others), By Tumor Size (0.2 cm3 to 100 cm3, 101 cm3 to 200 cm3, Above 200 cm3), by Region, Country, Segment, and Companies, 2024-2030
... Neuroma, Astrocytomas, Craniopharyngiomas, Ganglioneuromas, Glioblastoma Multiforme, Meningiomas, Ependymomas, Oligodendroglioma, Low-Grade Tumors, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Diagnostic Centers & Research Institutes, Others), By Tumor Size (0.2 cm3 to 100 cm3, 101 ... Read More
-
Antipsychotic Drugs Market Size, Trends, Analysis, and Outlook By Class Type, First Generation, Second Generation, Third generation), By Application (Schizophrenia, Bipolar disorders, Dementia, Unipolar Depression, Others), by Region, Country, Segment, and Companies, 2024-2030
... Antipsychotic Drugs market size is poised to register 7.88% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Antipsychotic Drugs market across By ... Read More
-
Mental Health Clinical Trials Market Size, Trends, Analysis, and Outlook By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Others), By Sponsor (Pharmaceutical & Biopharmaceutical Companies, Government Agencies, Others), By Disorder (Anxiety Disorders, Depression, Bipolar affective disorder, Dissociation and dissociative disorders, Schizophrenia, Others), by Region, Country, Segment, and Companies, 2024-2030
... By Disorder (Anxiety Disorders, Depression, Bipolar affective disorder, Dissociation and dissociative disorders, Schizophrenia, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Mental Health Clinical Trials market size is poised to register 8.98% growth ... Read More
-
Schizophrenia Drugs Market Size, Trends, Analysis, and Outlook By Treatment (Oral, Injectable), By Therapeutic Class (Second-Generation Antipsychotics (Risperdal, Invega, Zyprexa, Geodon, Seroquel, Latuda, Aristada, Fanapt, Saphris, Vraylar), Third-Generation Antipsychotics, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Schizophrenia Drugs market size is poised to register 5.41% growth from 2024 to 2030, presenting significant growth prospects for companies operating in ... Read More
-
Behavioral Health Care Software and Services Market Size, Trends, Analysis, and Outlook By Component (Software, Support Services), By Function (Clinical, Administrative, Financial), By Delivery Model (Ownership, Subscription), By End-User (Providers, Payers, Patients), By Disorder Type (Anxiety, Post-Traumatic Stress Disorder (PSTD), Substance Abuse, Schizophrenia, Bipolar Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030
... (Anxiety, Post-Traumatic Stress Disorder (PSTD), Substance Abuse, Schizophrenia, Bipolar Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Behavioral Health Care Software and Services market size is poised to register 11.75% growth from ... Read More
-
Regulatory Affairs Market Size, Trends, Analysis, and Outlook By Services (Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing, Product Registration & Clinical Trial Applications, Others), By Category, Drugs, Biosimilars, Medical Devices), By Indication (Oncology, Neurology, Cardiology, Immunology, Others), By Product (Preclinical, Clinical studies, PMA), By Service (In-house, Outsourced), By Organisation Size, Small, Medium, Large), By End-user (Medical Device Companies, Pharmaceutical Companies, Biotechnology Companies), by Region, Country, Segment, and Companies, 2024-2030
... Cardiology, Immunology, Others), By Product (Preclinical, Clinical studies, PMA), By Service (In-house, Outsourced), By Organisation Size, Small, Medium, Large), By End-user (Medical Device Companies, Pharmaceutical Companies, Biotechnology Companies), by Region, Country, Segment, and Companies, 2024-2030 ... Read More
Research Assistance
